Vimarsana
Biggest News Aggregation in the World

Page 39 - Contract Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contract Development Today - Breaking & Trending Today

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies - Vimarsana News

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

COLUMBUS, Ohio, Nov. 9, 2023 /PRNewswire/ -- Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Developmen...

Vetter's European Clinical Site Receives Permanent Manufacturer's Authorization - Vimarsana News

Vetter's European Clinical Site Receives Permanent Manufacturer's Authorization

Vetter Development Service Rankweil successfully completes re-inspectionSuccessful inspection completed at clinical siteInspectors were impressed with systems and processesAustrian site supports manufacturing and quality control of Human Investigational Medicinal ProductsRAVENSBURG, Germany & RANKWEIL, Austria--(BUS...

Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business - Vimarsana News

Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead the API business starting November 27, 2023, and will be base...

JB Pharma Q2 results: Net Profit up 35% to Rs 150.5 crore - Vimarsana News

JB Pharma Q2 results: Net Profit up 35% to Rs 150.5 crore

The pharma company had reported a net profit of Rs 111.1 crore in the year-ago period.

Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business - Vimarsana News

Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business

Teva Pharmaceutical Industries Ltd. today announced the appointment of Dr. R. Ananthanarayanan as CEO of its Teva Active Pharmaceutical Ingredients business . Dr. Ananth will lead the API business...